138 related articles for article (PubMed ID: 10490907)
1. Duration of cytochrome P-450 2E1 (CYP2E1) inhibition and estimation of functional CYP2E1 enzyme half-life after single-dose disulfiram administration in humans.
Emery MG; Jubert C; Thummel KE; Kharasch ED
J Pharmacol Exp Ther; 1999 Oct; 291(1):213-9. PubMed ID: 10490907
[TBL] [Abstract][Full Text] [Related]
2. Effect of disulfiram-mediated CYP2E1 inhibition on the disposition of vesnarinone.
Frye RF; Tammara B; Cowart TD; Bramer SL
J Clin Pharmacol; 1999 Nov; 39(11):1177-83. PubMed ID: 10579149
[TBL] [Abstract][Full Text] [Related]
3. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.
Nolin TD; Gastonguay MR; Bies RR; Matzke GR; Frye RF
Clin Pharmacol Ther; 2003 Dec; 74(6):555-68. PubMed ID: 14663458
[TBL] [Abstract][Full Text] [Related]
4. In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans.
Doroshyenko O; Fuhr U; Kunz D; Frank D; Kinzig M; Jetter A; Reith Y; Lazar A; Taubert D; Kirchheiner J; Baum M; Eisenbrand G; Berger FI; Bertow D; Berkessel A; Sörgel F; Schömig E; Tomalik-Scharte D
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):433-43. PubMed ID: 19190172
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity.
Dreisbach AW; Ferencz N; Hopkins NE; Fuentes MG; Rege AB; George WJ; Lertora JJ
Clin Pharmacol Ther; 1995 Nov; 58(5):498-505. PubMed ID: 7586943
[TBL] [Abstract][Full Text] [Related]
6. Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1.
Kharasch ED; Hankins DC; Jubert C; Thummel KE; Taraday JK
Drug Metab Dispos; 1999 Jun; 27(6):717-23. PubMed ID: 10348802
[TBL] [Abstract][Full Text] [Related]
7. Effect of high-dose aspirin on CYP2E1 activity in healthy subjects measured using chlorzoxazone as a probe.
Park JY; Kim KA; Park PW; Ha JM
J Clin Pharmacol; 2006 Jan; 46(1):109-14. PubMed ID: 16397290
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers.
Eap CB; Schnyder C; Besson J; Savary L; Buclin T
Clin Pharmacol Ther; 1998 Jul; 64(1):52-7. PubMed ID: 9695719
[TBL] [Abstract][Full Text] [Related]
9. Effects of steady-state lasofoxifene on CYP2D6- and CYP2E1-mediated metabolism.
Moller RA; Fisher JM; Taylor AE; Kolluri S; Gardner MJ; Obach RS; Walsky RL
Ann Pharmacother; 2006 Jan; 40(1):32-7. PubMed ID: 16368922
[TBL] [Abstract][Full Text] [Related]
10. Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans.
Gebhardt AC; Lucas D; Ménez JF; Seitz HK
Hepatology; 1997 Oct; 26(4):957-61. PubMed ID: 9328319
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress.
Leclercq I; Desager JP; Horsmans Y
Clin Pharmacol Ther; 1998 Aug; 64(2):144-9. PubMed ID: 9728894
[TBL] [Abstract][Full Text] [Related]
12. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease.
Emery MG; Fisher JM; Chien JY; Kharasch ED; Dellinger EP; Kowdley KV; Thummel KE
Hepatology; 2003 Aug; 38(2):428-35. PubMed ID: 12883487
[TBL] [Abstract][Full Text] [Related]
13. Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats.
Khemawoot P; Nishino K; Ishizaki J; Yokogawa K; Miyamoto K
Eur J Pharmacol; 2007 Nov; 574(1):71-6. PubMed ID: 17651723
[TBL] [Abstract][Full Text] [Related]
14. Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1.
Kharasch ED; Thummel KE; Mhyre J; Lillibridge JH
Clin Pharmacol Ther; 1993 Jun; 53(6):643-50. PubMed ID: 8513656
[TBL] [Abstract][Full Text] [Related]
15. Effect of the acute-phase response on the pharmacokinetics of chlorzoxazone and cytochrome P-450 2E1 in vitro activity in rats.
Rockich K; Blouin R
Drug Metab Dispos; 1999 Sep; 27(9):1074-7. PubMed ID: 10460809
[TBL] [Abstract][Full Text] [Related]
16. Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase.
Zhukov A; Ingelman-Sundberg M
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):453-8. PubMed ID: 10333489
[TBL] [Abstract][Full Text] [Related]
17. Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms.
Kim RB; O'Shea D
Clin Pharmacol Ther; 1995 Jun; 57(6):645-55. PubMed ID: 7781264
[TBL] [Abstract][Full Text] [Related]
18. [Changes of CYP2E1 activity in diabetic rat model].
Li L; Zhang Y
Yao Xue Xue Bao; 1998 Dec; 33(12):891-5. PubMed ID: 12016852
[TBL] [Abstract][Full Text] [Related]
19. Single-dose disulfiram does not inhibit CYP2A6 activity.
Kharasch ED; Hankins DC; Baxter PJ; Thummel KE
Clin Pharmacol Ther; 1998 Jul; 64(1):39-45. PubMed ID: 9695717
[TBL] [Abstract][Full Text] [Related]
20. Chlorzoxazone metabolism by winter flounder liver microsomes: evidence for existence of a CYP2E1-like isoform in teleosts.
Wall KL; Crivello J
Toxicol Appl Pharmacol; 1998 Jul; 151(1):98-104. PubMed ID: 9705891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
